Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. financial statements

Armata Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 4.9MEODHD
Net income−USD 173.8M10-K
Cash and equivalentsUSD 8.69M10-Q
Total debtUSD 288.02MEODHD

Armata Pharmaceuticals, Inc. financials on 6ix · Armata Pharmaceuticals, Inc. on 6ix